← Bird's Eye Reviews
Long Covid Clinical Trials
A bird's eye view of 326 clinical trials testing interventions for Long Covid.
Trials by publication year
Trials by country
046trials
Long Covid definition variability
Only 63% of trials require symptoms persisting ≥12 weeks (WHO standard)
Meets WHO definition (≥12 weeks)Below WHO threshold
Trials by intervention category
Each segment is one intervention — hover for name
Trials by primary symptom domain
Evidence landscape
Intervention category × symptom domain (cell = number of trials)
| Cognitive | Composite | Dyspnea | Exercise Capacity | Fatigue | Functional | Mental Health | Olfactory | Other | Overall | Pain | Quality Of Life | Sleep | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Inflammatory | – | – | 1 | 1 | 1 | – | – | 5 | 2 | – | – | – | – |
| Antiviral | – | – | 1 | – | 1 | – | – | – | – | 3 | – | 1 | – |
| Cell Therapy | – | – | 1 | – | 2 | – | – | 2 | – | – | – | – | – |
| Device | 2 | – | – | 1 | 3 | – | – | – | 5 | – | – | – | – |
| Exercise | – | – | 9 | 24 | 5 | – | 2 | – | 10 | 5 | 3 | 5 | – |
| Immunomodulator | – | – | 2 | – | 3 | – | – | – | 4 | 2 | – | – | – |
| Neurostimulation | 4 | – | 1 | 1 | 8 | – | 1 | – | 3 | – | 2 | 1 | 1 |
| Other | 3 | – | 3 | – | 6 | – | 3 | 3 | 11 | 5 | 3 | 2 | – |
| Oxygen Therapy | 2 | – | 2 | 1 | – | – | – | – | 2 | 2 | – | – | – |
| Probiotic | 1 | – | 1 | 1 | 3 | – | 1 | – | 2 | 4 | 1 | – | 1 |
| Psychological | 3 | – | – | – | 3 | 1 | 9 | – | – | 1 | 1 | 3 | 2 |
| Rehabilitation | 6 | – | 11 | 19 | 7 | 1 | 7 | 3 | 14 | 3 | 7 | 13 | 1 |
| Respiratory Therapy | – | – | 7 | 8 | – | – | – | – | 5 | 1 | – | 3 | – |
| Supplement | 5 | 1 | 2 | 6 | 14 | 2 | 6 | 7 | 15 | 11 | 7 | 4 | 2 |
Blinding type vs. statistical significance
Open-label trials tend to report more positive results
All Trials
326 trials match
| Paper | Intervention | Category | N ↓ | Outcome | # Out | + Sig | − / NS | Unk | % Pos | RoB | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.1016/j.cdnut.2024.103760 | Vitamin D3 (cholecalciferol) | Supplement | 1747 | — | 4 | — | — | 4 | 0% | Some concerns | |
| 10.2196/49342 | Diagnostic assessment plus tailored digital interventions plus personal pilot support | Rehabilitation | 1020 | Significant (p=0.00) | 3 | 2 | — | 1 | 67% | Some concerns | |
| 10.1016/j.eclinm.2024.102787 | amubarvimab/romlusevimab | Immunomodulator | 847 | Favors control (p=0.01) | 17 | — | 9 | 8 | 0% | Some concerns | |
| 10.1155/da/9989990 | Smartwatch-based monitoring with telemedical support | Device | 607 | — | 13 | — | — | 13 | 0% | Some concerns | |
| 10.1136/bmj.q346 | REGAIN (Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN) | Rehabilitation | 585 | Favors intervention (p=0.02) | 5 | 1 | 3 | 1 | 20% | Some concerns | |
| 10.1186/s12913-024-11679-5 | REGAIN online supervised group physical and mental health rehabilitation | Rehabilitation | 585 | No sig. diff. (p=0.90) | 5 | — | 3 | 2 | 0% | Some concerns | |
| 10.1136/bmjmed-2024-001068 | Listen personalised self-management support intervention | Psychological | 554 | No sig. diff. (p=0.05) | 14 | 9 | 5 | — | 64% | Some concerns | |
| 10.1111/hex.70357 | Personalised self-management support (LISTEN) | Psychological | 544 | No sig. diff. | 10 | — | — | 10 | 0% | Some concerns | |
| 10.1016/j.rpth.2024.102534 | enoxaparin | Other | 475 | No sig. diff. (p=0.50) | 14 | — | 3 | 11 | 0% | Some concerns | |
| 10.1016/s1473-3099(23)00685-0 | SIM01 synbiotic preparation | Probiotic | 463 | Favors intervention (p<.001) | 16 | 5 | 1 | 10 | 31% | Some concerns | |
| 10.14412/2074-2711-2021-2-65-7… | Actovegin (deproteinized hemoderivative of calf blood) | Other | 444 | No sig. diff. (p=0.05) | 4 | — | 2 | 2 | 0% | High | |
| 10.1111/jebm.12465 | Qingjin Yiqi granules (QJYQ) | Other | 388 | Favors intervention (p=0.01) | 4 | 2 | 2 | — | 50% | Some concerns | |
| 10.1093/ofid/ofae631.2200 | Ensitrelvir | Antiviral | 384 | No sig. diff. | 2 | — | — | 2 | 0% | Some concerns | |
| 10.1001/jamaneurol.2025.4415 | BrainHQ computerized cognitive training | Rehabilitation | 328 | No sig. diff. (p=0.98) | 12 | — | 1 | 11 | 0% | Low | |
| 10.1002/jcsm.13753 | Bosentan | Other | 313 | Significant (p=0.00) | 4 | 1 | — | 3 | 25% | Some concerns | |
| 10.3389/fcvm.2022.866113 | Sulodexide | Other | 290 | Significant (p=0.00) | 10 | — | — | 10 | 0% | High | |
| 10.1007/s00405-024-08802-x | Forskolin | Supplement | 285 | Significant (p<.001) | 6 | — | — | 6 | 0% | Some concerns | |
| 10.1183/13993003.03101-2021 | Inspiratory muscle training | Respiratory Therapy | 281 | No sig. diff. (p=0.05) | 14 | 1 | 5 | 8 | 7% | Some concerns | |
| 10.1007/s00405-023-08085-8 | Co-ultramicronized palmitoylethanolamide with luteolin plus olfactory training | Supplement | 250 | Favors intervention (p=0.01) | 6 | 1 | — | 5 | 17% | High | |
| 10.1038/s41467-025-64831-y | Pace Me app with just-in-time energy management messaging and Fitbit activity tracker | Device | 250 | No sig. diff. (p=0.61) | 14 | — | — | 14 | 0% | High | |
| 10.26766/pmgp.v9i3.526 | Remote medical-psychological rehabilitation program | Psychological | 248 | No sig. diff. (p=0.59) | 2 | — | 2 | — | 0% | High | |
| 10.26766/pmgp.v9i4.545 | Medical and Psychological Rehabilitation Program for Anxiety and Depressive Post-COVID Disorders in Remote Interaction Settings | Psychological | 248 | No sig. diff. (p=0.79) | 4 | — | 3 | 1 | 0% | Some concerns | |
| 10.1192/j.eurpsy.2025.463 | Proactive remote medical-psychological rehabilitation program | Psychological | 240 | Favors intervention (p=0.00) | 3 | 3 | — | — | 100% | High | |
| 10.26766/pmgp.v10i1.546 | Remote medical and psychological rehabilitation program | Psychological | 240 | Favors intervention (p=0.00) | 9 | 5 | — | 4 | 56% | High | |
| 10.1038/s41467-025-59909-6 | Counterweight-Plus remotely delivered weight management programme | Other | 234 | No sig. diff. | 8 | — | 1 | 7 | 0% | Some concerns | |
| 10.1038/s41591-024-03384-x | Counterweight-Plus remotely delivered weight management program | Other | 234 | Favors intervention (p<.001) | 16 | 11 | 4 | 1 | 69% | Some concerns | |
| 10.1001/jamanetworkopen.2025.3… | Personalized resistance exercise program | Exercise | 233 | Favors intervention (p=0.02) | 19 | 3 | 16 | — | 16% | Some concerns | |
| 10.1016/j.jgr.2025.04.007 | G1899 Korean Red Ginseng Extract Powder | Supplement | 220 | — | 14 | — | — | 14 | 0% | Some concerns | |
| 10.1093/ofid/ofac492.965 | Remdesivir | Antiviral | 208 | No sig. diff. | 10 | — | — | 10 | 0% | Some concerns | |
| 10.1182/blood-2024-209514 | Sulodexide | Other | 206 | Favors intervention (p=0.01) | 9 | 5 | — | 4 | 56% | Some concerns | |
| 10.1177/10760296241297647 | Sulodexide | Other | 206 | No sig. diff. (p=0.15) | 10 | 2 | 8 | — | 20% | Some concerns | |
| 10.1007/s11357-024-01179-z | Supervised cardiopulmonary rehabilitation | Rehabilitation | 200 | Significant (p=0.03) | 25 | — | 5 | 20 | 0% | High | |
| 10.3390/nu14112203 | Fermented Carica papaya + Morinda citrifolia syrups (BioRex Papaya + BioRex Noni) | Supplement | 188 | — | 18 | — | 12 | 6 | 0% | High | |
| 10.1183/23120541.01142-2024 | Deupirfenidone (LYT-100) | Anti-Inflammatory | 185 | No sig. diff. (p=0.70) | 8 | — | 4 | 4 | 0% | Some concerns | |
| 10.1183/13993003.02152-2024 | Face-to-face exercise-based rehabilitation | Rehabilitation | 181 | Favors intervention (p=0.00) | 15 | 1 | — | 14 | 7% | Low | |
| 10.38079/igusabder.1654185 | Therapist-supervised calisthenics exercise program | Exercise | 176 | No sig. diff. (p=0.12) | 6 | — | 6 | — | 0% | Some concerns | |
| 10.1038/s41598-024-82584-4 | Individualized symptom-titrated concurrent resistance and aerobic training | Exercise | 174 | Favors intervention (p=0.00) | 10 | 6 | — | 4 | 60% | High | |
| 10.34883/pi.2024.27.4.012 | Acupuncture reflexotherapy + therapeutic exercise with oriental gymnastics elements (yoga/qigong) + small-group psychotherapy | Rehabilitation | 166 | — | 12 | — | 5 | 7 | 0% | Some concerns | |
| 10.17816/568265 | Hydrotherapy whirlpool baths plus exercise therapy | Rehabilitation | 160 | — | 17 | — | — | 17 | 0% | Some concerns | |
| 10.18093/0869-0189-2023-33-1-5… | Bovhyaluronidase azoximer | Immunomodulator | 160 | Favors intervention (p=0.05) | 5 | 4 | 1 | — | 80% | High | |
| 10.26442/00403660.2022.11.2019… | Succinic acid complex with trimethylhydrazinium (Brainmax) | Supplement | 160 | Significant (p=0.00) | 19 | — | — | 19 | 0% | Some concerns | |
| 10.26442/00403660.2023.05.2022… | Succinic acid complex with trimethylhydrazinium (BRAINMAX) | Supplement | 160 | Significant (p=0.00) | 7 | 3 | 1 | 3 | 43% | Some concerns | |
| 10.3390/brainsci14121212 | Remote EMDR via AI-powered platform | Psychological | 160 | No sig. diff. (p=0.50) | 3 | — | 3 | — | 0% | Some concerns | |
| 10.3831/kpi.2023.26.3.238 | Acupuncture plus complex rehabilitation methods | Rehabilitation | 160 | Favors control (p=0.03) | 4 | 3 | 1 | — | 75% | High | |
| 10.15407/fz71.06.095 | Modified comprehensive pathogenetic regimen (hormonal + vascular-metabolic + neuroendocrine + micronutrient) | Other | 158 | No sig. diff. (p=0.05) | 15 | — | 15 | — | 0% | High | |
| 10.1371/journal.pone.0312714 | Interactive online occupational therapy | Rehabilitation | 158 | — | 8 | 3 | 5 | — | 38% | High | |
| 10.1001/jamainternmed.2024.200… | nirmatrelvir-ritonavir | Antiviral | 155 | — | 18 | 2 | 15 | 1 | 11% | Some concerns | |
| 10.64898/2025.12.04.25341650 | nirmatrelvir-ritonavir | Antiviral | 155 | — | 5 | — | — | 5 | 0% | Some concerns | |
| 10.3390/nu17020304 | Vitamin K2 (MK-7) + Vitamin D3 | Supplement | 151 | Favors intervention (p=0.04) | 19 | 2 | — | 17 | 11% | Some concerns | |
| 10.1016/s2213-2600(22)00125-4 | ENO Breathe online breathing and wellbeing programme | Rehabilitation | 150 | Favors intervention (p=0.05) | 12 | 2 | 10 | — | 17% | Some concerns | |
| 10.1007/s12325-024-02826-9 | vortioxetine | Other | 147 | Favors intervention (p=0.00) | 3 | 1 | — | 2 | 33% | High | |
| 10.1186/s12991-024-00494-1 | Vortioxetine | Other | 147 | Favors intervention (p=0.05) | 5 | 1 | — | 4 | 20% | Some concerns | |
| 10.1002/jcsm.13628 | Intermittent hypoxic-hyperoxic training (IHHT) | Respiratory Therapy | 145 | Favors intervention (p=0.00) | 18 | 7 | — | 11 | 39% | High | |
| 10.1093/eurheartj/ehad655.2594 | Intermittent hypoxic-hyperoxic training (IHHT) | Respiratory Therapy | 145 | Favors intervention (p=0.00) | 5 | 5 | — | — | 100% | Some concerns | |
| 10.17816/rjpbr628759 | Sequential MPGM followed by DSCBS via Magnon-2 | Brain Stimulation | 142 | — | 19 | — | — | 19 | 0% | High | |
| 10.24075/brsmu.2024.034 | Systemic ozone therapy (IV ozonized saline) + succinic acid complex with trimethylhydrazinium | Other | 140 | — | 9 | 9 | — | — | 100% | High | |
| 10.15275/rusomj.2025.0109 | Systemic ozone therapy (intravenous ozonated saline) plus Brainmax | Other | 140 | Significant (p=0.00) | 9 | — | — | 9 | 0% | Some concerns | |
| 10.1177/19458924231174799 | Omega-3 fatty acid supplementation | Supplement | 139 | No sig. diff. (p=0.22) | 4 | — | 2 | 2 | 0% | Some concerns | |
| 10.3390/jcm12216739 | Aerobic interval training on cycle ergometer | Exercise | 139 | No sig. diff. (p=0.16) | 18 | 1 | 12 | 5 | 6% | Some concerns | |
| 10.1186/s13690-024-01354-w | Online multimodal rehabilitation program | Rehabilitation | 134 | No sig. diff. (p=0.68) | 10 | 1 | 9 | — | 10% | Some concerns | |
| 10.1016/j.brat.2025.104917 | Cognitive Bias Modification for Interpretations (FLEX) | Psychological | 131 | — | 11 | — | — | 11 | 0% | Some concerns | |
| 10.1093/braincomms/fcaf447 | Cognitive-focused psychoeducational programme | Psychological | 130 | No sig. diff. (p=0.68) | 18 | — | 2 | 16 | 0% | Low | |
| 10.15789/2220-7619-doc-2042 | Interferon alpha-2b (recombinant), gel (Viferon) | Immunomodulator | 130 | Favors intervention (p=0.00) | 7 | 5 | — | 2 | 71% | High | |
| 10.3390/biomedicines11041109 | Ultramicronized palmitoylethanolamide 700mg + Luteolin 70mg plus olfactory training | Supplement | 130 | No sig. diff. (p=0.05) | 6 | — | 1 | 5 | 0% | High | |
| 10.1016/j.bjorl.2023.101356 | Alpha-lipoic acid | Supplement | 128 | No sig. diff. (p=0.63) | 6 | — | 4 | 2 | 0% | Some concerns | |
| 10.1016/j.imr.2024.101084 | Qigong exercise and acupressure rehabilitation program (QARP) | Rehabilitation | 128 | No sig. diff. (p=0.12) | 6 | 1 | 3 | 2 | 17% | Some concerns | |
| 10.17816/rjpbr692686 | VedaBiotic fifth-generation multisymbiotic plus standard rehabilitation | Probiotic | 128 | — | 22 | — | — | 22 | 0% | Some concerns | |
| 10.1016/j.lanepe.2022.100539 | Coenzyme Q10 | Supplement | 121 | No sig. diff. (p=0.32) | 11 | — | 2 | 9 | 0% | Some concerns | |
| 10.1001/jamanetworkopen.2025.0… | donepezil hydrochloride | Other | 120 | No sig. diff. (p=0.67) | 12 | — | 12 | — | 0% | Some concerns | |
| 10.1002/jcsm.13530 | Telerehabilitation (aerobic and strength circuit training) | Rehabilitation | 120 | Favors intervention (p=0.00) | 24 | 11 | 1 | 12 | 46% | Some concerns | |
| 10.1007/s00405-024-08548-6 | Ultramicronized palmitoylethanolamide and luteolin + olfactory training | Supplement | 120 | Significant (p=0.00) | 3 | — | — | 3 | 0% | High | |
| 10.28920/dhm55.2.104-113 | Hyperbaric oxygen therapy | Oxygen Therapy | 120 | — | 6 | — | — | 6 | 0% | Some concerns | |
| 10.29296/25877305-2023-08-11 | Virtual reality rehabilitation + robotic mechanotherapy with biofeedback + balance therapy + usual care | Rehabilitation | 120 | Significant (p=0.01) | 6 | 2 | — | 4 | 33% | High | |
| 10.29296/25877305-2023-09-11 | Robotic lower limb trainer (Con-Trex) + balance therapy (Stabilan 01-2) + virtual reality (Nirvana) plus standard rehabilitation | Rehabilitation | 120 | — | 6 | — | — | 6 | 0% | Some concerns | |
| 10.36425/rehab688680 | Personalized normobaric interval hypoxic-hyperoxic therapy (NBIHHT) plus standard rehabilitation | Oxygen Therapy | 120 | No sig. diff. (p=1.00) | 8 | — | 8 | — | 0% | Some concerns | |
| 10.38025/2078-1962-2023-22-2-1… | Robotic mechanotherapy (Con-Trex) + virtual reality training (Nirvana) + interactive balance therapy (Stabilan 01-2), plus basic rehabilitation | Rehabilitation | 120 | No sig. diff. (p=0.12) | 13 | — | — | 13 | 0% | Some concerns | |
| 10.38025/2078-1962-2025-24-5-3… | Personalized normobaric interval hypoxic-hyperoxic therapy (NBIHHT) plus basic rehabilitation | Oxygen Therapy | 120 | Favors intervention (p=0.02) | 17 | 9 | 1 | 7 | 53% | Some concerns | |
| 10.1186/s12967-022-03488-3 | Anhydrous Enol-Oxaloacetate (AEO) | Supplement | 119 | — | 7 | — | — | 7 | 0% | High | |
| 10.3390/jcm13040970 | Multidisciplinary group telerehabilitation | Rehabilitation | 116 | No sig. diff. (p=0.30) | 20 | — | — | 20 | 0% | Some concerns | |
| 10.3390/jcm14020486 | Multidisciplinary group telerehabilitation | Rehabilitation | 116 | No sig. diff. | 18 | 1 | — | 17 | 6% | Some concerns | |
| 10.1093/cid/ciad257 | Cognitive-behavioral therapy | Psychological | 114 | Favors intervention (p=0.00) | 8 | 8 | — | — | 100% | Some concerns | |
| 10.64898/2025.12.30.25343085 | Transcutaneous auricular vagus nerve stimulation (taVNS) | Neurostimulation | 114 | Favors intervention (p=0.00) | 6 | 2 | — | 4 | 33% | High | |
| 10.3390/ijms26178623 | High-intensity interval training | Exercise | 112 | No sig. diff. (p=0.84) | 8 | — | — | 8 | 0% | Some concerns | |
| 10.3390/life12101483 | Mometasone furoate nasal spray + olfactory training | Anti-Inflammatory | 112 | No sig. diff. | 6 | — | — | 6 | 0% | Some concerns | |
| 10.1038/s41386-024-01995-z | AKL-T01 (EndeavorOTC) | Device | 110 | No sig. diff. (p=0.95) | 10 | — | — | 10 | 0% | Some concerns | |
| 10.1097/cm9.0000000000003459 | Human umbilical cord-derived mesenchymal stem cells (UC-MSCs) | Cell Therapy | 110 | — | 10 | — | 8 | 2 | 0% | High | |
| 10.15212/amm-2024-0089 | Cordyceps sinensis mycelium culture extract (Cs4) | Supplement | 110 | Favors intervention (p=0.00) | 11 | 8 | 3 | — | 73% | Some concerns | |
| 10.21760/jaims.10.11.10 | Vardhamana Pippali Rasayana with Mrudwika Sharkara | Supplement | 110 | Favors intervention (p=0.01) | 13 | 13 | — | — | 100% | Some concerns | |
| 10.1186/s40560-023-00669-0 | Helmet noninvasive ventilation | Respiratory Therapy | 109 | No sig. diff. (p=0.71) | 34 | — | 33 | 1 | 0% | Some concerns | |
| 10.30629/2658-7947-2025-30-3-5… | Cytoflavin (inosine + nicotinamide + riboflavin + succinic acid) | Supplement | 106 | — | 27 | 6 | — | 21 | 22% | High | |
| 10.7416/ai.2025.2678 | Mindfulness-Based Stress Reduction (MBSR) | Psychological | 105 | No sig. diff. (p=0.62) | 15 | 8 | 6 | 1 | 53% | Some concerns | |
| 10.18370/2309-4117.2023.69.104… | Femicycle or Femimens (Ayurvedic phytocompositions) | Supplement | 104 | No sig. diff. | 18 | — | — | 18 | 0% | High | |
| 10.20969/vskm.2022.15(1).26-33 | Trecresan (oxymethyluracil derivative, adaptogen/immunomodulator) | Immunomodulator | 103 | Favors intervention (p=0.00) | 6 | 4 | 2 | — | 67% | High | |
| 10.1186/s13287-025-04148-1 | Human umbilical cord-derived mesenchymal stem cells (UC-MSC) | Cell Therapy | 101 | — | 15 | 1 | 11 | 3 | 7% | Some concerns | |
| 10.1007/s40121-025-01287-z | Self-help lymphatic drainage intervention (Perrin technique) | Rehabilitation | 100 | Favors intervention (p=0.01) | 1 | 1 | — | — | 100% | High | |
| 10.1038/s41598-023-35058-y | ReCOVery telerehabilitation APP | Rehabilitation | 100 | No sig. diff. (p=0.23) | 12 | — | 12 | — | 0% | Some concerns | |
| 10.1155/2023/7068326 | Amygdala and Insula Retraining (AIR) / The Gupta Program | Psychological | 100 | No sig. diff. (p=0.29) | 2 | — | 2 | — | 0% | High | |
| 10.1155/ijcp/7692776 | ReCOVery APP telerehabilitation | Rehabilitation | 100 | No sig. diff. (p=0.05) | 10 | — | 10 | — | 0% | Some concerns | |
| 10.1186/s12879-023-08172-5 | Fluvoxamine | Immunomodulator | 100 | Favors control (p=0.03) | 12 | — | 12 | — | 0% | Some concerns | |
| 10.3390/ph15030345 | Chisan/ADAPT-232 (Rhodiola rosea + Schisandra chinensis + Eleutherococcus senticosus) | Supplement | 100 | No sig. diff. (p=0.27) | 21 | — | 10 | 11 | 0% | Some concerns | |
| 10.48035/tesis/2454/53703 | Muscle power resistance training | Exercise | 100 | Favors intervention (p=0.00) | 16 | 1 | — | 15 | 6% | Some concerns | |
| 10.21926/obm.icm.2401010 | Electroacupuncture according to Voll (EAV) diagnosis with medicament testing using RNA polymerase nosode, ribavirin, and dexamethasone | Other | 99 | Favors intervention (p=0.00) | 17 | 12 | 1 | 4 | 71% | High | |
| 10.1186/s12906-025-04784-3 | Balneotherapy plus aquatic exercises | Rehabilitation | 98 | Favors control (p=0.03) | 15 | — | 15 | — | 0% | Some concerns | |
| 10.1038/s41598-025-07461-0 | Intermittent fasting with extended water-only fasts | Other | 96 | Favors intervention (p=0.01) | 7 | 3 | — | 4 | 43% | High | |
| 10.1192/j.eurpsy.2024.257 | L-arginine + SSRI | Supplement | 96 | Significant (p=0.01) | 2 | — | — | 2 | 0% | Some concerns | |
| 10.3390/jcm14228193 | Low-level laser therapy | Device | 93 | Significant (p<.001) | 6 | — | — | 6 | 0% | Some concerns | |
| 10.3390/nu18030521 | Alfacalcidol plus vitamin D3 supplementation with dietary counseling, sun exposure guidance, and exercise therapy | Supplement | 91 | Favors intervention (p=0.00) | 5 | 1 | 1 | 3 | 20% | High | |
| 10.1177/09727531241306849 | Bhramari Pranayama | Respiratory Therapy | 90 | Favors intervention (p=0.04) | 5 | 3 | 1 | 1 | 60% | High | |
| 10.19163/2307-9266-2025-13-4-2… | L-carnitine | Supplement | 90 | No sig. diff. (p=0.05) | 33 | 2 | 5 | 26 | 6% | High | |
| 10.20953/1729-9225-2021-4-15-2… | Azoximer bromide (Polyoxidonium) | Immunomodulator | 90 | Favors control (p<.001) | 12 | 5 | 2 | 5 | 42% | High | |
| 10.1002/ctm2.1436 | Polymerised type I collagen | Immunomodulator | 89 | — | 10 | — | — | 10 | 0% | High | |
| 10.1016/j.rehab.2022.101709 | Inspiratory muscle training | Respiratory Therapy | 88 | No sig. diff. | 11 | — | — | 11 | 0% | Low | |
| 10.1183/23120541.00838-2024 | Water-based exercise | Exercise | 86 | — | 14 | 4 | — | 10 | 29% | Some concerns | |
| 10.3390/jcm12196244 | Water-based exercise training | Exercise | 86 | No sig. diff. | 9 | — | — | 9 | 0% | Some concerns | |
| 10.3390/s23198120 | Standard neurological rehabilitation + EMG-driven rehabilitation robot (Luna EMG) | Rehabilitation | 86 | No sig. diff. (p=0.08) | 18 | 1 | 17 | — | 6% | Some concerns | |
| 10.1152/japplphysiol.00489.202… | Concurrent training (resistance + endurance) | Exercise | 83 | — | 15 | — | 5 | 10 | 0% | Some concerns | |
| 10.14412/1996-7012-2022-3-67-7… | Parenteral chondroitin sulfate (Chondroguard) + celecoxib | Supplement | 82 | Favors intervention (p<.001) | 14 | 1 | — | 13 | 7% | High | |
| 10.1002/lary.30353 | Mometasone furoate | Anti-Inflammatory | 80 | No sig. diff. (p=0.95) | 10 | 4 | 3 | 3 | 40% | Some concerns | |
| 10.1016/j.bjpt.2025.101247 | Aerobic exercise + diaphragmatic breathing exercise | Exercise | 80 | Favors intervention (p=0.00) | 7 | 7 | — | — | 100% | Some concerns | |
| 10.1093/eurheartj/suac012.353 | L-arginine + liposomal vitamin C | Supplement | 80 | No sig. diff. | 1 | — | — | 1 | 0% | High | |
| 10.1136/bmjopen-2024-094386 | Hyperbaric oxygen treatment | Oxygen Therapy | 80 | No sig. diff. (p=0.87) | 9 | — | 9 | — | 0% | Low | |
| 10.1038/s41598-023-36570-x | Hyperbaric oxygen therapy | Oxygen Therapy | 79 | No sig. diff. (p=0.24) | 12 | — | — | 12 | 0% | Some concerns | |
| 10.1038/s41598-022-15565-0 | Hyperbaric oxygen therapy | Oxygen Therapy | 79 | Favors intervention (p=0.04) | 21 | 9 | 12 | — | 43% | Low | |
| 10.3390/healthcare13222914 | Motion-controlled video game-based virtual reality exercise | Exercise | 79 | Favors intervention (p=0.00) | 7 | 3 | 4 | — | 43% | Low | |
| 10.1177/27536130251385551 | Triphala | Supplement | 78 | No sig. diff. (p=0.29) | 12 | — | 12 | — | 0% | Some concerns | |
| 10.51910/ijhdr.v25icf.1532 | Individualized homeopathic medicine | Other | 77 | No sig. diff. (p=0.40) | 7 | — | 7 | — | 0% | Some concerns | |
| 10.1136/bmjresp-2025-003653 | Stepwise pulmonary rehabilitation programme | Rehabilitation | 76 | Favors intervention (p=0.02) | 20 | 9 | 2 | 9 | 45% | Some concerns | |
| 10.5606/tftrd.2025.14301 | Low-intensity interval moderate-intensity aerobic training | Exercise | 76 | No sig. diff. | 19 | — | — | 19 | 0% | Some concerns | |
| 10.21802/artm.2024.1.29.142 | Comprehensive geriatric rehabilitation program | Rehabilitation | 75 | — | 13 | — | 11 | 2 | 0% | High | |
| 10.21802/artm.2023.4.28.108 | Comprehensive geriatric-oriented physical therapy program | Rehabilitation | 75 | No sig. diff. (p=0.05) | 5 | — | 2 | 3 | 0% | Some concerns | |
| 10.1101/2022.10.04.22280680 | Elderberry extract (Sambucus nigra L.) - Immunodaat | Supplement | 74 | No sig. diff. (p=0.05) | 26 | — | 17 | 9 | 0% | High | |
| 10.1183/23120541.00031-2024 | Lactoferrin | Supplement | 72 | No sig. diff. (p=1.00) | 7 | — | — | 7 | 0% | Low | |
| 10.1186/s13102-024-00817-5 | Online-supported individualized physical activity program | Exercise | 72 | No sig. diff. | 12 | — | — | 12 | 0% | Some concerns | |
| 10.3389/fphys.2023.1219252 | Multi-professional intervention (concurrent training + nutritional education + psychoeducation) | Rehabilitation | 71 | No sig. diff. (p=0.63) | 24 | — | 8 | 16 | 0% | High | |
| 10.1016/j.brs.2023.01.1672 | High-Definition transcranial Direct Current Stimulation | Neurostimulation | 70 | Favors intervention (p=0.00) | 8 | 6 | 2 | — | 75% | Some concerns | |
| 10.24884/1682-6655-2025-24-1-4… | Dynamic inversion table (gravitational therapy) | Device | 70 | Favors intervention (p=0.00) | 5 | 4 | — | 1 | 80% | Some concerns | |
| 10.3390/ijerph21101385 | Face-to-face Mat Pilates training | Exercise | 70 | Significant (p=0.01) | 21 | 2 | 1 | 18 | 10% | Some concerns | |
| 10.51793/os.2022.25.2.005 | Bifiform (Bifidobacterium longum BB-46 + Enterococcus faecium ENCfa-68) + antispasmodics + antidiarrheals | Probiotic | 70 | Significant (p=0.00) | 6 | — | — | 6 | 0% | High | |
| 10.3389/fnins.2025.1627462 | Oxaloacetate (anhydrous enol-oxaloacetate) | Supplement | 69 | No sig. diff. (p=0.71) | 28 | 2 | 20 | 6 | 7% | Some concerns | |
| 10.1186/s12984-024-01340-x | Home-based pulmonary rehabilitation (HBPR) | Rehabilitation | 68 | Favors intervention (p=0.00) | 5 | 4 | — | 1 | 80% | Some concerns | |
| 10.1038/s41598-025-09772-8 | tDCS over primary motor cortex combined with cognitive training | Neurostimulation | 67 | No sig. diff. (p=0.17) | 18 | — | — | 18 | 0% | Some concerns | |
| 10.1038/s41598-024-51904-z | Amantadine | Other | 66 | Favors intervention (p=0.00) | 2 | 2 | — | — | 100% | High | |
| 10.23736/s1973-9087.24.08487-9 | Supervised endurance exercise training | Exercise | 66 | Favors intervention (p=0.00) | 13 | 1 | 9 | 3 | 8% | Some concerns | |
| 10.1007/s11845-025-03899-3 | Telerehabilitation-based exercise program | Rehabilitation | 64 | Favors control (p=0.00) | 6 | — | 6 | — | 0% | Some concerns | |
| 10.1136/spcare-2023-004595 | Astragalus root extract | Supplement | 64 | Favors control (p=0.01) | 3 | — | 3 | — | 0% | Some concerns | |
| 10.4193/rhin21.470 | Olfactory training using Sniffin' Sticks (Duft-Quartett) | Rehabilitation | 63 | No sig. diff. (p=0.43) | 12 | 7 | 2 | 3 | 58% | High | |
| 10.3390/jcm13206237 | Pulmonary rehabilitation plus progressive muscle relaxation | Rehabilitation | 61 | — | 11 | 2 | 2 | 7 | 18% | Some concerns | |
| 10.1016/j.brs.2024.12.534 | Active tDCS plus online cognitive training (BrainHQ) | Neurostimulation | 60 | Significant (p=0.04) | 2 | — | — | 2 | 0% | Some concerns | |
| 10.1016/j.brs.2025.08.018 | Transcranial direct current stimulation plus cognitive training | Neurostimulation | 60 | No sig. diff. (p=0.92) | 15 | 1 | 11 | 3 | 7% | Some concerns | |
| 10.1016/j.imr.2023.101001 | Aromatherapy essential oil inhalation | Other | 60 | No sig. diff. (p=0.59) | 5 | — | 5 | — | 0% | High | |
| 10.1016/j.jpsychores.2023.1113… | Famotidine | Other | 60 | No sig. diff. (p=0.78) | 4 | — | 4 | — | 0% | Some concerns | |
| 10.1016/j.rehab.2023.101765 | Exercise training rehabilitation | Exercise | 60 | Favors intervention (p<.001) | 8 | 6 | 2 | — | 75% | Some concerns | |
| 10.1093/eurheartj/ehad655.2601 | Cardiopulmonary rehabilitation program | Rehabilitation | 60 | No sig. diff. | 4 | — | — | 4 | 0% | Some concerns | |
| 10.1101/2022.08.29.22279327 | Endurance training rehabilitation | Exercise | 60 | No sig. diff. (p=0.85) | 8 | 1 | 7 | — | 13% | Some concerns | |
| 10.1111/hex.70399 | Long COVID Optimal Health Programme (LC-OHP) | Psychoeducation/Self-Management | 60 | — | 6 | — | — | 6 | 0% | Some concerns | |
| 10.1186/s12967-022-03660-9 | Treamid (bisamide derivative of dicarboxylic acid, BDDA) | Anti-Inflammatory | 60 | Significant (p=0.04) | 12 | — | 10 | 2 | 0% | Some concerns | |
| 10.15829/1728-8800-2021-2986 | Active hydrogen inhalation (H(H2O)m) | Respiratory Therapy | 60 | — | 19 | 2 | 1 | 16 | 11% | High | |
| 10.19163/1994-9480-2022-19-2-4… | Transcutaneous supraorbital nerve stimulation (t-SNS) with Cefaly device | Neurostimulation | 60 | No sig. diff. (p=0.05) | 13 | — | — | 13 | 0% | Some concerns | |
| 10.2340/jrm.v54.3972 | Manual diaphragm release plus inspiratory muscle training (POWERbreath) | Respiratory Therapy | 60 | Favors intervention (p=0.00) | 7 | 7 | — | — | 100% | Some concerns | |
| 10.2340/jrm.v56.25491 | Incentive spirometry | Respiratory Therapy | 60 | Favors intervention (p=0.00) | 10 | 10 | — | — | 100% | Some concerns | |
| 10.25259/ijmr_827_2024 | Progressive Muscle Relaxation Technique + Spinal Muscle Training | Exercise | 60 | Favors intervention (p=0.00) | 2 | 2 | — | — | 100% | High | |
| 10.26355/eurrev_202402_35361 | High-frequency chest wall oscillation (Vest device) | Respiratory Therapy | 60 | No sig. diff. (p=0.06) | 6 | — | 6 | — | 0% | Some concerns | |
| 10.31080/asms.2023.07.1491 | Transcranial low-frequency magnetotherapy | Neurostimulation | 60 | — | 3 | 3 | — | — | 100% | Some concerns | |
| 10.3389/fresc.2025.1588940 | Thermal spa resort rehabilitation | Rehabilitation | 60 | No sig. diff. (p=0.05) | 16 | — | — | 16 | 0% | High | |
| 10.3390/jcm12062233 | Cardiopulmonary rehabilitation program | Rehabilitation | 60 | Favors intervention (p=0.00) | 5 | 5 | — | — | 100% | Some concerns | |
| 10.4235/agmr.24.0175 | Slow deep breathing exercise | Respiratory Therapy | 60 | — | 16 | — | 4 | 12 | 0% | Some concerns | |
| 10.58727/jshr.107257 | Circuit training with aerobic, strength and breathing exercises | Exercise | 60 | Favors intervention (p=0.04) | 8 | 4 | 4 | — | 50% | Some concerns | |
| 10.1590/fm.2023.36112 | Multicomponent physiotherapy (strength, resistance, balance, gait) | Exercise | 59 | No sig. diff. (p=0.13) | 3 | — | 3 | — | 0% | Some concerns | |
| 10.3390/jcm13020425 | Comprehensive exercise training + active Threshold IMT | Rehabilitation | 59 | No sig. diff. (p=0.28) | 13 | — | — | 13 | 0% | Some concerns | |
| 10.38025/2078-1962-2023-22-4-9… | Audiovisual stimulation (AVS) + cognitive behavioral psychotherapy (CBT) | Psychological | 59 | No sig. diff. (p=0.05) | 10 | — | — | 10 | 0% | Some concerns | |
| 10.1016/j.eclinm.2025.103633 | nicotinamide riboside | Supplement | 58 | No sig. diff. (p=0.49) | 13 | — | 7 | 6 | 0% | High | |
| 10.1002/clc.70110 | Low-level tragus stimulation | Neurostimulation | 57 | No sig. diff. (p=0.05) | 8 | — | — | 8 | 0% | Some concerns | |
| 10.1016/j.apmr.2025.05.008 | Pain Informed Movement program | Rehabilitation | 57 | Favors control (p=0.00) | 15 | — | 15 | — | 0% | Some concerns | |
| 10.1093/cid/ciac226 | leronlimab | Immunomodulator | 55 | No sig. diff. | 3 | — | — | 3 | 0% | Some concerns | |
| 10.36740/abal202201102 | Citicoline + Vinpocetine + Nootropil (Piracetam) + Cerebrolysin IV infusion | Other | 54 | Favors intervention (p=0.01) | 10 | 8 | — | 2 | 80% | High | |
| 10.3390/biomedicines12102221 | Marine oil enriched in SPMs (specialized pro-resolving mediators) | Supplement | 53 | Significant (p=0.00) | 8 | — | — | 8 | 0% | Some concerns | |
| 10.1001/jamanetworkopen.2024.3… | Lithium aspartate | Supplement | 52 | No sig. diff. (p=0.59) | 17 | — | 17 | — | 0% | Some concerns | |
| 10.3390/jcm12030776 | 14-day therapeutic exercise telerehabilitation program (breathing + strength exercises) | Exercise | 52 | — | 5 | 5 | — | — | 100% | Some concerns | |
| 10.1016/j.heliyon.2024.e40453 | Combined aerobic, resistance, and breathing exercise program | Exercise | 51 | No sig. diff. (p=0.92) | 21 | — | 21 | — | 0% | High | |
| 10.1007/s10103-023-03917-9 | Photobiomodulation 660nm | Device | 50 | No sig. diff. (p=0.56) | 9 | — | — | 9 | 0% | High | |
| 10.1038/s41467-025-57198-7 | Therapeutic plasma exchange | Device | 50 | — | 10 | — | — | 10 | 0% | Some concerns | |
| 10.1080/21679169.2025.2479676 | Pulmonary telerehabilitation | Rehabilitation | 50 | No sig. diff. (p=0.56) | 20 | — | 20 | — | 0% | Some concerns | |
| 10.1136/bjsports-2022-106681 | Home-based exercise training programme | Exercise | 50 | Favors intervention (p=0.00) | 20 | 5 | 9 | 6 | 25% | Some concerns | |
| 10.1177/19458924221120116 | Sodium gluconate intranasal spray | Other | 50 | Favors intervention (p<.001) | 5 | 2 | — | 3 | 40% | Some concerns | |
| 10.17816/rjpbr109501 | Interval hypo-hyperoxic training (IHHT) via OXYTERRA device | Oxygen Therapy | 50 | No sig. diff. | 23 | — | — | 23 | 0% | High | |
| 10.26717/bjstr.2024.59.009252 | Echinochrome A (EchA Marine dietary supplement) | Supplement | 50 | Significant (p=0.01) | 11 | 2 | — | 9 | 18% | Some concerns | |
| 10.3390/ijerph19041992 | Molecular hydrogen (H2) inhalation | Respiratory Therapy | 50 | Favors intervention (p=0.00) | 15 | 6 | 9 | — | 40% | Some concerns | |
| 10.3390/nu14234984 | L-arginine plus liposomal vitamin C | Supplement | 50 | Favors intervention (p=0.00) | 5 | 4 | — | 1 | 80% | Some concerns | |
| 10.3390/nu14153004 | 1-Methylnicotinamide (1-MNA) | Supplement | 50 | Favors intervention (p=0.00) | 6 | 1 | 3 | 2 | 17% | High | |
| 10.5455/njppp.2024.14.04187202… | Nintedanib | Other | 50 | No sig. diff. (p=0.23) | 8 | — | 8 | — | 0% | High | |
| 10.3390/brainsci14070693 | Hybrid exercise (supervised + tele-exercise) | Exercise | 49 | — | 24 | 1 | 1 | 22 | 4% | Some concerns | |
| 10.3390/jcm13102747 | Resistance training (RT) | Exercise | 49 | Significant (p=0.00) | 14 | — | — | 14 | 0% | Some concerns | |
| 10.1093/braincomms/fcad117 | Transcranial direct current stimulation (tDCS) | Neurostimulation | 48 | No sig. diff. (p=0.18) | 8 | — | — | 8 | 0% | Low | |
| 10.2147/oajct.s389489 | Intranasal insulin fast-dissolving film | Other | 48 | — | 10 | — | — | 10 | 0% | High | |
| 10.5195/ijt.2023.6560 | Telerehabilitation exercise training | Exercise | 47 | — | 7 | 3 | 1 | 3 | 43% | Some concerns | |
| 10.1101/2023.05.31.23290798 | Echinochrome A (sea urchin egg extract) | Supplement | 46 | No sig. diff. (p=0.26) | 7 | — | — | 7 | 0% | Some concerns | |
| 10.1186/s12872-024-04196-0 | Home-based breathing and chest mobility exercise | Respiratory Therapy | 46 | Favors intervention (p=0.03) | 11 | 4 | 7 | — | 36% | Some concerns | |
| 10.3390/jcm13061712 | 8-week progressive resistance training | Exercise | 46 | Favors intervention (p<.001) | 15 | 5 | 10 | — | 33% | Some concerns | |
| 10.1016/j.ctim.2022.102823 | Longevity essential oil blend (thyme, orange, clove bud, frankincense) | Other | 44 | Favors intervention (p=0.02) | 7 | 7 | — | — | 100% | Some concerns | |
| 10.14744/ejp.2024.1204 | Transcutaneous auricular vagus nerve stimulation (taVNS) | Neurostimulation | 44 | — | 9 | 4 | 1 | 4 | 44% | Some concerns | |
| 10.63144/ijt.2025.6716 | Synchronous telerehabilitation with physiotherapist supervision | Exercise | 44 | Favors intervention (p=0.03) | 7 | 1 | 6 | — | 14% | Some concerns | |
| 10.1016/j.eclinm.2025.103730 | Intranasal and transcranial photobiomodulation (Vielight Neuro RX Gamma) | Neurostimulation | 43 | No sig. diff. (p=0.09) | 9 | 1 | 2 | 6 | 11% | Some concerns | |
| 10.1155/ijcp/5641307 | Transcutaneous auricular vagus nerve stimulation | Neurostimulation | 42 | No sig. diff. (p=0.13) | 8 | — | 8 | — | 0% | Some concerns | |
| 10.11604/pamj.2023.46.65.36615 | Respiratory muscle training program | Respiratory Therapy | 42 | — | 19 | — | 11 | 8 | 0% | High | |
| 10.22141/2308-2097.58.2.2024.6… | 5-strain Bacillus probiotic (B.subtilis, B.licheniformis, B.amyloliquefaciens, B.megaterium, B.pumilus) | Probiotic | 42 | No sig. diff. (p=0.05) | 8 | — | 6 | 2 | 0% | High | |
| 10.22416/1382-4376-2022-32-6-4… | Omeprazole + Kolofort (technologically processed antibodies to S100, TNF-alpha, histamine) | Other | 42 | Significant (p=0.01) | 11 | — | 5 | 6 | 0% | High | |
| 10.3390/jcm14176066 | Osteopathic manipulative treatment (OMT) | Other | 42 | Favors intervention (p=0.01) | 10 | 1 | 4 | 5 | 10% | Some concerns | |
| 10.3390/jcm14124225 | Hybrid pulmonary rehabilitation (outpatient + home-based) | Rehabilitation | 42 | Favors intervention (p<.001) | 21 | 9 | 8 | 4 | 43% | High | |
| 10.36425/rehab608182 | Intermittent hypoxia-hyperoxia therapy (ReOxy) | Respiratory Therapy | 42 | No sig. diff. (p=0.05) | 3 | — | 3 | — | 0% | Some concerns | |
| 10.5334/ijic.icic23285 | Hybrid Integrated Care Program (outpatient PR + home-based ICT-supported follow-up) | Rehabilitation | 42 | — | 7 | — | — | 7 | 0% | High | |
| 10.1016/j.eclinm.2023.101946 | AXA1125 | Supplement | 41 | No sig. diff. (p=0.24) | 9 | 3 | 2 | 4 | 33% | Some concerns | |
| 10.1186/s12868-025-00989-x | Anodal transcranial direct current stimulation (tDCS) | Neurostimulation | 41 | — | 13 | 1 | 3 | 9 | 8% | Some concerns | |
| 10.1186/s13287-022-02972-3 | Human umbilical cord mesenchymal stem cells (hUC-MSCs) | Cell Therapy | 41 | Significant (p=0.03) | 14 | 2 | 7 | 5 | 14% | Some concerns | |
| 10.1080/09602011.2024.2338613 | Cardiopulmonary rehabilitation (aerobic + resistance + respiratory exercises) | Rehabilitation | 40 | — | 20 | 2 | 1 | 17 | 10% | Some concerns | |
| 10.1186/s43163-023-00478-0 | Dexamethasone | Anti-Inflammatory | 40 | No sig. diff. (p=0.51) | 2 | — | 1 | 1 | 0% | Some concerns | |
| 10.13189/saj.2025.130406 | Baduanjin Exercise Training | Exercise | 40 | Favors intervention (p=0.00) | 12 | 12 | — | — | 100% | Some concerns | |
| 10.20953/1817-7646-2023-1-28-3… | Ammonium glycyrrhizinate (Reglisam) | Anti-Inflammatory | 40 | Favors intervention (p=0.04) | 7 | 1 | — | 6 | 14% | High | |
| 10.21802/artm.2025.1.33.13 | Tivorel (levocarnitine + arginine hydrochloride) + Quercetin | Supplement | 40 | — | 24 | — | — | 24 | 0% | High | |
| 10.33667/2078-5631-2022-35-8-1… | Bacillus subtilis metabolites + fructooligosaccharides (Baktiminal) | Probiotic | 40 | Favors intervention (p<.001) | 10 | 2 | — | 8 | 20% | Some concerns | |
| 10.3389/fpsyg.2025.1582742 | Tablet-based cognitive, relaxation, and physiotherapy training | Rehabilitation | 40 | No sig. diff. (p=0.45) | 21 | — | 1 | 20 | 0% | Some concerns | |
| 10.3390/jcm14010272 | Structured orofacial rehabilitation program | Rehabilitation | 40 | No sig. diff. | 4 | — | — | 4 | 0% | High | |
| 10.36028/2308-8826-2025-13-2-8… | Individually dosed hypoxi-hyperoxic therapy (IDHHT) plus physical therapy with cluster sets | Oxygen Therapy | 40 | — | 5 | 2 | — | 3 | 40% | High | |
| 10.38025/2078-1962-2024-23-1-3… | Human placenta hydrolyzate Laennec IV infusion + multimodal rehabilitation | Immunomodulator | 40 | — | 18 | — | — | 18 | 0% | Some concerns | |
| 10.47026/2413-4864-2022-2-1-8 | Alpha-rhythm neurofeedback training (Neuro V) | Neurostimulation | 40 | — | 4 | — | 4 | — | 0% | High | |
| 10.55572/jms.v2i2.51 | Structured cardiopulmonary exercise training, moderate intensity | Exercise | 40 | Favors intervention (p=0.01) | 1 | 1 | — | — | 100% | High | |
| 10.56199/dpcsms.sjjq1180 | Osteopathic manipulative treatment | Rehabilitation | 40 | No sig. diff. | 5 | — | — | 5 | 0% | High | |
| 10.1016/j.clinph.2022.10.017 | Co-ultramicronized palmitoylethanolamide/luteolin | Supplement | 39 | Significant (p=0.03) | 9 | — | — | 9 | 0% | Some concerns | |
| 10.1038/s41598-025-27036-3 | Heat-treated Lacticaseibacillus paracasei PS23 | Probiotic | 39 | — | 16 | 3 | 10 | 3 | 19% | Some concerns | |
| 10.1111/sms.14240 | Tailored multicomponent concurrent exercise training | Exercise | 39 | Favors intervention (p=0.04) | 19 | 12 | 7 | — | 63% | Some concerns | |
| 10.14393/hygeia2071233 | Supervised physical exercise program | Exercise | 39 | No sig. diff. | 16 | — | — | 16 | 0% | Some concerns | |
| 10.14393/hygeia2071051 | Pilates method | Exercise | 39 | No sig. diff. | 19 | 1 | — | 18 | 5% | Some concerns | |
| 10.1101/2023.06.28.23291986 | VSL#3® (multi-strain probiotic) | Probiotic | 38 | Significant (p=0.01) | 21 | — | — | 21 | 0% | Some concerns | |
| 10.17267/2238-2704rpf.2024.e58… | Comprehensive rehabilitation (aerobic, strength, balance, flexibility, breathing exercise, education) | Rehabilitation | 38 | Favors intervention (p=0.01) | 7 | 3 | 1 | 3 | 43% | Some concerns | |
| 10.1007/s00508-025-02501-1 | Transcutaneous auricular vagus nerve stimulation 10Hz | Neurostimulation | 36 | — | 11 | — | — | 11 | 0% | Some concerns | |
| 10.1136/annrheumdis-2022-eular… | Interval hypoxic-hyperoxic training (Reoxy therapy) | Oxygen Therapy | 36 | — | 7 | — | — | 7 | 0% | Some concerns | |
| 10.1186/s12903-023-02952-w | Diode laser 940 nm (EPIC, BIOLASE) | Device | 36 | Significant (p=0.00) | 4 | — | — | 4 | 0% | Some concerns | |
| 10.15395/mkb.v55n2.2753 | WHO Stress Management module | Psychological | 36 | Favors intervention (p<.001) | 2 | 1 | — | 1 | 50% | High | |
| 10.3389/fmolb.2022.1016352 | Mountain spa rehabilitation + ubiquinol (CoQ10) | Rehabilitation | 36 | — | 18 | 3 | 1 | 14 | 17% | High | |
| 10.3389/fneur.2025.1523814 | C1-esterase inhibitor (RUCONEST) | Immunomodulator | 36 | — | 14 | — | 2 | 12 | 0% | Some concerns | |
| 10.1038/s41598-024-52763-4 | Transcranial direct current stimulation | Neurostimulation | 35 | No sig. diff. (p=0.63) | 9 | — | 9 | — | 0% | Some concerns | |
| 10.1080/13548506.2024.2439180 | Asynchronous telerehabilitation (HEFORA app) with physical therapy and therapeutic education | Rehabilitation | 35 | No sig. diff. (p=0.46) | 11 | — | 8 | 3 | 0% | Some concerns | |
| 10.1007/s00406-024-01904-x | Cognitive training and group psychotherapy | Psychological | 34 | — | 20 | 3 | — | 17 | 15% | High | |
| 10.26442/00403660.2024.03.2026… | Inhaled nitric oxide plus molecular hydrogen (iNO/iH2) | Respiratory Therapy | 34 | — | 17 | — | — | 17 | 0% | High | |
| 10.32592/ircmj.2023.25.4.2080 | Hydroxychloroquine | Immunomodulator | 34 | No sig. diff. (p=0.72) | 6 | — | 5 | 1 | 0% | Some concerns | |
| 10.3390/ijerph20021361 | Rebalance neuro-meditation program | Psychological | 34 | Favors intervention (p=0.01) | 21 | 14 | 3 | 4 | 67% | High | |
| 10.54033/cadpedv21n7-221 | Cardiopulmonary rehabilitation | Rehabilitation | 34 | No sig. diff. | 10 | — | — | 10 | 0% | Some concerns | |
| 10.11606/issn.2317-0190.v30i4a… | Cardiopulmonary physiotherapy rehabilitation program | Rehabilitation | 33 | Favors control (p=0.03) | 12 | — | 8 | 4 | 0% | High | |
| 10.3390/ph17040463 | Echinacea angustifolia + rosehip + propolis + royal jelly + zinc supplement | Supplement | 33 | — | 19 | 3 | 1 | 15 | 16% | Some concerns | |
| 10.1111/hex.70079 | Personalised health behaviour support programme | Rehabilitation | 32 | — | 16 | — | — | 16 | 0% | Some concerns | |
| 10.3389/fpubh.2023.1121554 | Virtual reality-based pulmonary rehabilitation | Rehabilitation | 32 | No sig. diff. (p=0.26) | 10 | — | 10 | — | 0% | Some concerns | |
| 10.3390/nu16101529 | Hydrogen-rich water | Supplement | 32 | Favors intervention (p=0.05) | 8 | 4 | 4 | — | 50% | Some concerns | |
| 10.7759/cureus.76148 | Omega-3 (EPA+DHA) | Supplement | 32 | — | 7 | — | 5 | 2 | 0% | High | |
| 10.1089/can.2022.0135 | Cannabidiol-rich whole-flower hemp preparation (Formula C) | Supplement | 31 | No sig. diff. | 10 | — | — | 10 | 0% | High | |
| 10.3389/fpsyg.2024.1441018 | Multimodal immersive virtual reality (cognitive training + physical exercise + mindfulness) | Rehabilitation | 31 | Favors intervention (p=0.03) | 21 | 6 | 3 | 12 | 29% | High | |
| 10.1002/alr.23116 | Platelet-rich plasma | Cell Therapy | 30 | No sig. diff. (p=0.13) | 6 | — | 5 | 1 | 0% | Some concerns | |
| 10.1016/j.clinme.2024.100251 | Sulphur thermal water inhalation | Respiratory Therapy | 30 | — | 15 | — | — | 15 | 0% | Some concerns | |
| 10.1016/j.eclinm.2025.103358 | Rovunaptabin (BC007) | Immunomodulator | 30 | No sig. diff. (p=0.13) | 12 | 7 | 1 | 4 | 58% | Some concerns | |
| 10.1016/j.eclinm.2025.103737 | REGENECYTE (HPC, Cord Blood) | Cell Therapy | 30 | — | 14 | 10 | 4 | — | 71% | Some concerns | |
| 10.1038/s41598-024-78651-5 | Transcutaneous Electrical Nerve Stimulation (high-dose) | Neurostimulation | 30 | Favors intervention (p=0.01) | 12 | 1 | 2 | 9 | 8% | Some concerns | |
| 10.1182/blood-2024-210709 | RegeneCyte (human umbilical cord blood, HPC) | Cell Therapy | 30 | — | 2 | — | — | 2 | 0% | Some concerns | |
| 10.20969/vskm.2025.18(6).64-71 | Enhanced external counterpulsation (EECP) | Device | 30 | — | 8 | — | — | 8 | 0% | High | |
| 10.31655/2307-3373-2024-3-5-15 | Erdosteine plus breathing exercises plus ICS/formoterol | Other | 30 | No sig. diff. | 14 | — | — | 14 | 0% | High | |
| 10.32598/jrh.12.6.2046.1 | Mindfulness-based cognitive therapy (MBCT) | Psychological | 30 | Favors intervention (p<.001) | 2 | 2 | — | — | 100% | High | |
| 10.3390/ijerph191610398 | EMG-triggered rehabilitation robot (Luna EMG) plus standard neurological rehabilitation | Device | 30 | No sig. diff. (p=0.91) | 5 | — | — | 5 | 0% | High | |
| 10.36106/paripex/8204857 | Structured physiotherapy exercise protocol with breathing exercises | Rehabilitation | 30 | Significant (p=0.00) | 5 | — | — | 5 | 0% | High | |
| 10.37506/ijpot.v16i2.18051 | Pulmonary telerehabilitation (breathing exercises + therapeutic exercises) | Rehabilitation | 30 | Significant (p<.001) | 2 | — | — | 2 | 0% | High | |
| 10.37506/pkxqyr14 | Diaphragmatic strength training + resistance exercise | Exercise | 30 | Favors intervention (p<.001) | 2 | 2 | — | — | 100% | High | |
| 10.52403/ijhsr.20230310 | Balloon blowing technique plus diaphragmatic breathing exercise | Respiratory Therapy | 30 | No sig. diff. (p=0.45) | 3 | — | 3 | — | 0% | High | |
| 10.52403/ijhsr.20230305 | Aerobic exercise plus diaphragmatic breathing exercise | Exercise | 30 | No sig. diff. (p=0.87) | 4 | — | 4 | — | 0% | High | |
| 10.5114/biolsport.2024.139072 | Cardiopulmonary rehabilitation programme (CPRP) | Rehabilitation | 30 | Favors intervention (p=0.00) | 15 | 8 | 7 | — | 53% | Some concerns | |
| 10.61453/intij.202342 | Body weight exercises (push-ups, squats, plank, burpee) | Exercise | 30 | No sig. diff. (p=0.05) | 2 | 1 | 1 | — | 50% | High | |
| 10.1113/ep092099 | High-intensity interval training (HIIT) | Exercise | 28 | Favors intervention (p=0.02) | 26 | 3 | 19 | 4 | 12% | Some concerns | |
| 10.1007/s00394-024-03546-0 | Synbiotic (L. rhamnosus DSM 32550, L. plantarum DSM 34532, B. lactis DSM 32269, B. longum DSM 32946, fructooligosaccharides, zinc) | Probiotic | 26 | No sig. diff. (p=0.90) | 17 | — | — | 17 | 0% | Some concerns | |
| 10.1136/bmjresp-2022-001439 | Home-based inspiratory muscle training | Respiratory Therapy | 26 | Favors intervention (p=0.00) | 11 | 7 | 1 | 3 | 64% | Some concerns | |
| 10.3390/brainsci13071014 | Oral vitamin A plus aerosolised diffuser olfactory training | Supplement | 26 | Favors intervention (p=0.00) | 5 | 1 | — | 4 | 20% | Some concerns | |
| 10.3390/nu16223840 | Multispecies probiotic mixture (OMNi-BiOTiC Pro-Vi 5) | Probiotic | 26 | Significant (p=0.05) | 10 | — | — | 10 | 0% | High | |
| 10.1590/1806-9282.20230666 | Platelet-rich plasma injection into olfactory cleft | Cell Therapy | 25 | No sig. diff. (p=0.99) | 2 | — | 2 | — | 0% | High | |
| 10.1186/s13063-024-08473-3 | Supervised aerobic exercise training (HIIT or MIIT on cycling ergometer) | Exercise | 24 | Favors intervention (p=0.00) | 22 | 6 | 14 | 2 | 27% | Some concerns | |
| 10.21518/ms2023-111 | Ethylmethylhydroxypyridine malate (Mexidol) | Supplement | 24 | No sig. diff. | 10 | 1 | — | 9 | 10% | High | |
| 10.3389/fcogn.2025.1692578 | Vibratory and auditory treatment (VAT) at 40 Hz | Device | 22 | Significant (p=0.01) | 8 | — | — | 8 | 0% | Some concerns | |
| 10.1371/journal.pone.0312735 | Supplemental oxygen via portable oxygen concentrator | Oxygen Therapy | 21 | No sig. diff. | 20 | — | — | 20 | 0% | Some concerns | |
| 10.31532/physmedrehabil.2.1.00… | Physiotherapist-supervised group telerehabilitation exercise | Exercise | 21 | — | 10 | — | 10 | — | 0% | Some concerns | |
| 10.1007/s00508-025-02522-w | Pulsed electromagnetic field therapy (Papimi Delta) | Device | 20 | — | 16 | — | — | 16 | 0% | High | |
| 10.1186/s12879-023-08002-8 | Hyperbaric oxygen therapy | Oxygen Therapy | 20 | Favors control (p=0.00) | 7 | — | 5 | 2 | 0% | Some concerns | |
| 10.1371/journal.pone.0340965 | Eccentric cycling | Exercise | 20 | Favors intervention (p=0.02) | 12 | 5 | 7 | — | 42% | Some concerns | |
| 10.17816/acen.1358 | EEG alpha-rhythm biofeedback (neurofeedback) training | Neurostimulation | 20 | — | 26 | — | — | 26 | 0% | Some concerns | |
| 10.3389/fpubh.2023.1115393 | Stationary cycling with virtual reality headset | Rehabilitation | 20 | Favors intervention (p=0.00) | 5 | 1 | — | 4 | 20% | Some concerns | |
| 10.3390/jpm14050515 | Supervised physiotherapy program (interval aerobic + resistance exercise) | Exercise | 20 | No sig. diff. | 4 | — | — | 4 | 0% | High | |
| 10.7759/cureus.87026 | Olfactory training with budesonide nasal irrigations | Rehabilitation | 20 | — | 2 | — | — | 2 | 0% | High | |
| 10.1164/rccm.202309-1572oc | Inspiratory muscle training (IMT) | Respiratory Therapy | 18 | No sig. diff. (p=0.05) | 13 | 3 | 10 | — | 23% | Some concerns | |
| 10.14814/phy2.15636 | Electrical stimulation (E-Stim) to gastrocnemius muscles | Neurostimulation | 18 | Significant (p=0.00) | 11 | 1 | 2 | 8 | 9% | Some concerns | |
| 10.3390/brainsci15050510 | NESA XSIGNAL superficial neuromodulation | Neurostimulation | 18 | Favors intervention (p=0.02) | 17 | 1 | 16 | — | 6% | Some concerns | |
| 10.3390/jcm14155363 | Heart Rate Variability Biofeedback (HRV-BF) | Device | 18 | Significant (p=0.04) | 12 | — | 1 | 11 | 0% | High | |
| 10.4193/rhin20.515 | Prednisone (systemic) + nasal irrigation with betamethasone, ambroxol, and rinazine | Anti-Inflammatory | 18 | No sig. diff. (p=0.59) | 2 | — | — | 2 | 0% | Some concerns | |
| 10.3389/fspor.2022.877188 | Remote adapted physical activity plus therapeutic education | Exercise | 17 | Favors intervention (p=0.01) | 11 | 1 | — | 10 | 9% | High | |
| 10.1038/s43856-025-01322-7 | Beclomethasone | Anti-Inflammatory | 15 | No sig. diff. (p=0.54) | 3 | — | 2 | 1 | 0% | Some concerns | |
| 10.3177/jnsv.70.174 | Creatine monohydrate | Supplement | 15 | Favors intervention (p=0.01) | 6 | 1 | 5 | — | 17% | Some concerns | |
| 10.1007/s00431-025-06705-5 | Individualized online exercise therapy | Exercise | 14 | No sig. diff. | 12 | — | — | 12 | 0% | Some concerns | |
| 10.1109/jiot.2022.3188914 | Telerehabilitation with telecoaching plus home exercise | Rehabilitation | 14 | — | 6 | — | — | 6 | 0% | Some concerns | |
| 10.1016/j.brs.2021.10.368 | Transcutaneous auricular vagus nerve stimulation (taVNS) | Neurostimulation | 13 | — | 4 | — | — | 4 | 0% | High | |
| 10.1002/fsn3.3597 | Creatine monohydrate | Supplement | 12 | Significant (p=0.01) | 16 | — | — | 16 | 0% | High | |
| 10.1097/md.0000000000041583 | Pulmonary rehabilitation plus evidence-based eHealth education tool | Rehabilitation | 12 | No sig. diff. (p=0.45) | 24 | 1 | 22 | 1 | 4% | Some concerns | |
| 10.1126/scitranslmed.adu4284 | Larazotide (AT1001) | Other | 12 | Significant (p=0.00) | 12 | 1 | — | 11 | 8% | Some concerns | |
| 10.1186/s42234-022-00094-y | Transcutaneous auricular vagus nerve stimulation (taVNS) | Neurostimulation | 12 | — | 6 | — | — | 6 | 0% | Some concerns | |
| 10.3389/fnut.2023.1131192 | Ketone ester (D-beta-hydroxybutyrate ester) | Supplement | 12 | No sig. diff. (p=0.66) | 23 | 6 | 17 | — | 26% | Low | |
| 10.1017/s1355617723007634 | Constraint-Induced Cognitive Therapy (CICT) | Rehabilitation | 9 | No sig. diff. (p=0.05) | 3 | — | 2 | 1 | 0% | High | |
| 10.4081/mrm.2022.886 | Nebivolol | Other | 8 | No sig. diff. | 9 | — | — | 9 | 0% | Some concerns | |
| 10.4103/jpgm.jpgm_650_23 | Creatine monohydrate plus breathing exercises | Supplement | 8 | No sig. diff. (p=0.06) | 23 | 5 | 18 | — | 22% | Some concerns | |
| 10.1007/s10072-023-07268-9 | Dual-task augmented reality rehabilitation | Rehabilitation | — | — | 9 | — | — | 9 | 0% | High | |
| 10.1037/rep0000626 | Constraint-Induced Cognitive Therapy | Rehabilitation | — | — | 8 | — | 2 | 6 | 0% | Some concerns | |
| 10.1038/s41598-025-96555-w | Awe intervention (AWE technique) | Psychological | — | Favors intervention (p=0.00) | 6 | 3 | 3 | — | 50% | High | |
| 10.1055/a-2535-0153 | Functional septorhinoplasty | Other | — | No sig. diff. (p=0.06) | 13 | — | 8 | 5 | 0% | High | |
| 10.1093/eurheartj/ehae666.298 | Cardiopulmonary rehabilitation program | Rehabilitation | — | No sig. diff. (p=0.94) | 3 | — | 3 | — | 0% | High | |
| 10.26442/00403660.2022.03.2013… | Inhaled hydrogen gas (active form) | Respiratory Therapy | — | Favors intervention (p<.001) | 10 | 2 | — | 8 | 20% | High | |
| 10.29011/2688-996x.001043 | L-arginine + liposomal vitamin C (bioarginina C) | Supplement | — | No sig. diff. | 10 | — | 3 | 7 | 0% | High | |
| 10.3389/fmed.2021.758405 | Methylprednisolone | Anti-Inflammatory | — | Favors intervention (p=0.01) | 11 | 2 | 9 | — | 18% | Some concerns | |
| 10.3389/fphys.2024.1416639 | Tailored mixed exercise program | Exercise | — | — | 13 | 1 | — | 12 | 8% | High | |
| 10.3390/ijerph192214905 | Online forest bathing | Psychological | — | — | 4 | 4 | — | — | 100% | High | |
| 10.3390/ijms25158305 | Nordic walking exercise therapy | Exercise | — | — | 2 | — | — | 2 | 0% | High | |
| 10.3390/jcm13041035 | Nordic Walking program | Exercise | — | Significant (p=0.02) | 16 | — | 4 | 12 | 0% | High | |
| 10.3390/jcm14010174 | Resistance training program | Exercise | — | No sig. diff. (p=0.81) | 14 | — | 14 | — | 0% | Some concerns | |
| 10.3390/medicina62010210 | Core-stabilization plank exercise program | Exercise | — | Favors intervention (p=0.00) | 6 | 3 | — | 3 | 50% | High | |
| 10.3390/life13071563 | Transcutaneous spinal cord stimulation (scTS) | Neurostimulation | — | Favors intervention (p=0.04) | 5 | 4 | 1 | — | 80% | High | |
| 10.3390/nu17040723 | Curcuma longa + Boswellia serrata (lecithin-based) + low-FODMAP diet | Supplement | — | Favors intervention (p=0.00) | 4 | 2 | 1 | 1 | 50% | High | |
| 10.3390/v14122614 | Bacteriophage cocktails (oral and inhalation) | Other | — | — | 36 | — | — | 36 | 0% | High | |
| 10.4149/bll_2023_013 | Ubiquinol plus mountain spa rehabilitation | Supplement | — | Favors intervention (p<.001) | 16 | 3 | — | 13 | 19% | High |